|
|
|
LifeScienceHistory.com - Check us out on Instagram
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
SillaJen Biotherapeutics, Inc.
| | | Phone: | (415) 281-8886 | Year Established: | 2007 | Main Contact: | Helena Chaye Ph.D., LL.B., CBO | | Other Contacts: | Robin L. Scully, VP, Product and Alliance Management Ursula Fritsch, Senior VP, Regulatory Affairs and Quality Assurance James M. Burke, CMO Georg Roth, CT)
| | Company Description | SillaJen Biotherapeutics, formerly, is a clinical-stage company that focuses on developing and commercializing oncolytic immunotherapy products to treat cancer. The company specializes in the research, development, and manufacture of oncolytic viruses for targeting, attacking, and eradicating cancer. Its product includes Pexa-Vec (pexastimogene devacirepvec), an attenuated (weakened) Wyeth strain vaccinia virus engineered to directly lyse tumor cells and stimulate anti-tumor immunity. | |
|
|
|
|
|